ARS Pharmaceuticals Inc — Cash Flow (NASDAQ:SPRY) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 66.76 M40.08 M59.27 M13.55 M 112.47 M Cash from investing activities 66.48 M199 K87.18 M106.1 M 134.41 M Cash from financing activities 614 K190.73 M6.9 M72.4 M 174.38 M Free cash flow 65.39 M39.88 M59.09 M12.98 M 111.83 M

Noticias

ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)

What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)

Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)

China aprueba el primer spray nasal de epinefrina para alergias de uso comunitario

China approves first community use epinephrine nasal spray for allergies

CBO de ARS Pharma, Chakma, vende acciones por valor de 1,47 millones de dólares

Director comercial de ARS Pharma vende acciones por $1.47 mil millones

Dorsey, director de operaciones de ARS Pharma, vende 190.000 dólares en acciones SPRY

Dorsey, director de operaciones de ARS Pharma, vende $190k en acciones SPRY

ARS Pharma CBO Chakma sells shares worth $1.47 million

Dorsey, ARS Pharma COO, sells $190k in SPRY stock

ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript